mylan
-
Defective EpiPens Cited In Deaths Of At Least 7 Americans So Far In 2017
This year’s worldwide recall of defective EpiPens has put people with severe allergies on alert. And now allergy sufferers have even more reasons to worry. Faulty EpiPens have been cited in the deaths of at least seven Americans so far this year, according to FDA reports that have only been made public this week.
-
US Senator: EpiPen Manufacturer Ripped Off The US Government For $1.7 Billion
For people with severe allergies, having an EpiPen can mean the difference between life and death. Because there’s no generic alternative, EpiPen manufacturer Mylan just keeps jacking up the price and ripping off patients. They also seem to have ripped off the US government. Today, a probe by the US Department of Health and Human…
-
Mylan Ripped Off The US Government, Ironically By Misclassifying EpiPens As A Generic Drug
The US government spent over $US1.3 billion ($1.7 billion) on EpiPens from 2011 to 2015. But Mylan, the makers of EpiPen, has been overcharging the government for the life-saving allergy medication by misclassifying it as a generic, rather than a name brand drug. If you don’t know whether to laugh or cry at this point,…
-
The US Senate Is Now Looking Into The EpiPen Price Hike
On Wednesday, the Senate’s permanent subcommittee on investigations announced it was launching a probe into the pricing of Mylan’s EpiPen, the life-saving allergy treatment device which cost about $US57 ($74) in 2007 and is priced at around $US600 ($782) today.